Cancer Chemotherapy and Cardiovascular Risks: Is Capecitabine-Induced Hypertriglyceridemia a Rare Adverse Effect?

Publisher： Karger

E-ISSN： 1421-9751|116|1|42-44

ISSN： 0008-6312

Source： Cardiology, Vol.116, Iss.1, 2010-04, pp. : 42-44

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Case of Capecitabine-induced Hyperammonemia in a Patient with Colon Cancer

By  

Current Drug Safety, Vol. 13, Iss. 1, 2018-03 ,pp. : 55-58

Bentham Science Publishers

Access to resources Recommend Favorite

Capecitabine-Induced Coronary Vasospasm

By  

Case Reports in Oncology, Vol. 9, Iss. 3, 2016-10 ,pp. : 629-632

Karger

Access to resources Recommend Favorite

Oxaliplatin-Induced Leukocytoclastic Vasculitis under Adjuvant Chemotherapy for Colorectal Cancer: Two Cases of a Rare Adverse Event

By  

Case Reports in Oncology, Vol. 6, Iss. 3, 2013-12 ,pp. : 609-615

Karger

Access to resources Recommend Favorite

An unusual cardiovascular adverse effect of donepezil

By  

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 8, 2015-08 ,pp. : 877-878

John Wiley & Sons Inc

Access to resources Recommend Favorite

First-Line Chemotherapy with Irinotecan plus Capecitabine for Advanced Colorectal Cancer

By  

Oncology, Vol. 66, Iss. 5, 2004-09 ,pp. : 353-357

Karger

Access to resources Recommend Favorite